REQUEST A DEMO
Total
USD $0.00
Search more companies

Humed Pharma d.o.o. (Croatia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Humed Pharma d.o.o. Profile Updated: August 05, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Humed Pharma d.o.o. is an enterprise in Croatia, with the main office in Zagreb. The enterprise currently operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. The enterprise was incorporated on December 11, 2025. The total number of employees is currently 13 (2024). From the latest financial highlights, Humed Pharma d.o.o. reported a net sales revenue increase of 4.55% in 2024. Over the same period, its total assets grew by 81.9%. The net profit margin of Humed Pharma d.o.o. increased by 7.51% in 2024.

Headquarters
Miramarska Cesta 36 Str.
Zagreb; City of Zagreb; Postal Code: 10000

Contact Details: Purchase the Humed Pharma d.o.o. report to view the information.

Website: http://www.humed-pharma.hr

Basic Information
Total Employees:
Purchase the Humed Pharma d.o.o. report to view the information.
Financial Auditors:
Purchase the Humed Pharma d.o.o. report to view the information.
Incorporation Date:
December 11, 2025
Key Executives
Purchase this report to view the information.
Manager
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Humed Pharma d.o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
4.55%
Total operating revenue
4.55%
Operating profit (EBIT)
228.97%
EBITDA
262.61%
Net Profit (Loss) for the Period
251.77%
Total assets
81.9%
Total equity
324.46%
Operating Profit Margin (ROS)
9.17%
Net Profit Margin
7.51%
Return on Equity (ROE)
-5.46%
Debt to Equity Ratio
-49.54%
Quick Ratio
-0.22%
Cash Ratio
-0.27%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?